Chongkundang Holdings
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Chongkundang Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.
Its business activities are conducted through those subsidiaries, which operate in the pharmaceutical and health-care space. The company's filing covers a consolidated group structure, with multiple subsidiaries consolidated into its financial reporting.
Summary is AI-generated and may contain errors · figures from DART filings
As a holding company, it does not directly manufacture or distribute products itself; its value is tied to the performance of its underlying subsidiaries.
Chongkundang Holdings in five facts
What does Chongkundang Holdings do?
Chongkundang Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.
Where is Chongkundang Holdings listed and in which sector?
Chongkundang Holdings (Korean name: 종근당홀딩스) trades under KRX code 001630 on KOSPI, the main board of the Korea Exchange. It is classified in the Health Care sector, Pharmaceuticals.
How large is Chongkundang Holdings?
Its market capitalisation was US$135M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Chongkundang Holdings's latest annual revenue and operating profit?
For fiscal year 2025, Chongkundang Holdings reported revenue of US$723.8M, operating profit of US$44M and net income of US$41M, per its annual report on DART (data retrieved from DART on 2026-09-06). Revenue was up 0.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-06
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Half-year report (2026.06)Oct 12
- [Amended] Material event report (business suspension) (subsidiary)Sep 30
- Report on large shareholdings (5% rule) (standard)Sep 30
- [Amended] Material event report (business suspension) (subsidiary)Aug 31
- Supply contract terminated (subsidiary)Supply contract · Apr 10
- Cash/in-kind dividend decision (subsidiary)Dividend · Mar 11
- Cash/in-kind dividend decision
Chongkundang Holdings declared a cash dividend of US$0.97 per share.
Dividend · Feb 25 - Cash/in-kind dividend decision (subsidiary)Dividend · Feb 24
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Chongkundang Holdings reported consolidated results for FY2025: revenue of US$659M (+0.1% year on year), operating profit of US$40M (+64.2% year on year) and net income of US$37.3M (+34.8% year on year).
Earnings · Feb 11 - Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)Earnings · Feb 2
- Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)Earnings · Feb 2
- Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)Earnings · Jan 30